Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/6/2025
-
GuruFocus
5/6/2025
-
BizJournals.com - Nat'l Business News
5/6/2025
-
Globe Newswire
5/5/2025
-
Bizjournals.com - Comm. Real Estate
5/1/2025
-
GuruFocus
5/1/2025
-
TipRanks Financial Blog
5/1/2025
-
The Fly
5/1/2025
-
Globe Newswire
4/29/2025
-
Ticker Report
4/16/2025
-
TipRanks Financial Blog
4/15/2025
-
GuruFocus
4/15/2025
-
The Fly
4/15/2025
-
The Fly
4/15/2025
-
Globe Newswire
3/26/2025
-
The Fly
3/26/2025
-
PR Newswire
3/24/2025
-
Benzinga
3/24/2025
-
PR Newswire
3/24/2025
-
TipRanks Financial Blog
3/24/2025
-
Seeking Alpha - Healthcare
3/24/2025
-
The Fly
3/24/2025
-
GuruFocus
3/24/2025
-
Globe Newswire
3/21/2025
-
MarketBeat
3/20/2025
-
Benzinga
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, April 15, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
215 488 9300
Address
2600 Kelly Road
Warrington, PA 18976-3622
Warrington, PA 18976-3622
Country
Year Founded
Business Description
Sector
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company’s lead product candidate is...
more